Viewing Study NCT04053634


Ignite Creation Date: 2025-12-25 @ 2:32 AM
Ignite Modification Date: 2025-12-26 @ 1:07 AM
Study NCT ID: NCT04053634
Status: COMPLETED
Last Update Posted: 2025-08-19
First Post: 2019-07-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent Exacerbations
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module